<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">a-phenotype-based-model-for-rational-selection-of</item><item key="factor_count">1</item><item key="sample_count">14</item><item key="tags"><item>basal</item><item>breast</item><item>cancer</item><item>cell</item><item>histone</item><item>phosphatidylinositol</item><item>primary breast cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-18331</item><item key="id">3434</item><item key="name">A phenotype-based model for rational selection of novel targeted therapies in treating aggressive breast cancer</item></item><item><item key="slug">calactin-a-small-molecule-induces-dna-damage-and-h</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>histone</item><item>leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-20928</item><item key="id">3614</item><item key="name">Calactin - a small molecule induces DNA damage and histione modification in leukemia cells</item></item><item><item key="slug">commonly-altered-genomic-regions-in-acute-myeloid</item><item key="factor_count">1</item><item key="sample_count">17</item><item key="tags"><item>acute myeloid leukemia</item><item>histone</item><item>leukemia</item><item>myeloid leukemia</item><item>nucleotide</item><item>point</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-38987</item><item key="id">4517</item><item key="name">Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin-remodeling and splicing</item></item><item><item key="slug">ctcf-demarcates-chromatin-domains</item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>chromatin</item><item>genome</item><item>histone</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-12889</item><item key="id">3026</item><item key="name">CTCF demarcates chromatin domains</item></item><item><item key="slug">expression-data-of-neural-progenitor-cells-differe</item><item key="factor_count">3</item><item key="sample_count">5</item><item key="tags"><item>histone</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-61050</item><item key="id">4820</item><item key="name">Expression data of neural progenitor cells differentiation from human embryonic stem cells</item></item><item><item key="slug">expression-profiling-of-dnmt1-inhibitors-in-hct116</item><item key="factor_count">0</item><item key="sample_count">24</item><item key="tags"><item>disease</item><item>histone</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-30985</item><item key="id">4183</item><item key="name">Expression profiling of DNMT1 inhibitors in HCT116 cells</item></item><item><item key="slug">expression-profiling-of-mixed-lineage-leukemia-cel</item><item key="factor_count">6</item><item key="sample_count">24</item><item key="tags"><item>cell</item><item>histone</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29828</item><item key="id">4127</item><item key="name">Expression Profiling of Mixed Lineage Leukemia Cells Treated with a Potent Small-Molecule DOT1L Inhibitor</item></item><item><item key="slug">ezh2-inhibition-as-a-therapeutic-strategy-for-lymp</item><item key="factor_count">5</item><item key="sample_count">46</item><item key="tags"><item>cell</item><item>histone</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-40972</item><item key="id">4582</item><item key="name">EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2 Activating Mutations</item></item><item><item key="slug">ezh2-mutations-can-be-detected-in-23-of-picalm-mll</item><item key="factor_count">4</item><item key="sample_count">29</item><item key="tags"><item>acute leukemia</item><item>deep</item><item>exon</item><item>histone</item><item>leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-30599</item><item key="id">4170</item><item key="name">EZH2 mutations can be detected in 23% of PICALM-MLLT10 (CALM-AF10) positive acute leukemias</item></item><item><item key="slug">gata2-in-human-vascular-endothelial-cells</item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>chromatin</item><item>distal</item><item>endothelial cell</item><item>endothelium</item><item>genome</item><item>histone</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28304</item><item key="id">4017</item><item key="name">GATA2 in human vascular endothelial cells</item></item></data></biogps>
